AzurRx BioPharma Insider Trades

AZRX

Track insider trading activity from AzurRx BioPharma executives and directors. See which insiders are buying and selling AZRX stock.

Trades Last 12 Months

AZRX Price

All Insider Trades for AzurRx BioPharma

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Romano Sarah Chief Financial Officer
Holding Value $518k 150,000 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$528k 150,000 shares
$3.52
$3.45
Holding Value $119k 34,482 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$121k 34,482 shares
$3.52
$3.45
Holding Value $119k 34,482 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$121k 34,482 shares
$3.52
$3.45
Oakes Gregory Director
Holding Value $119k 34,482 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$121k 34,482 shares
$3.52
$3.45
Borkowski Edward Director
Holding Value $119k 34,482 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$121k 34,482 shares
$3.52
$3.45
Pennington James CHIEF MEDICAL OFFICER
Holding Value $25.9k 7,500 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.4k 7,500 shares
$3.52
$3.45
Riddell Alastair Director
Holding Value $119k 34,482 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$121k 34,482 shares
$3.52
$3.45
Sapirstein James Pres, CEO & CHAIRMAN OF BOARD
Holding Value $518k 150,000 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$528k 150,000 shares
$3.52
$3.45
Schneiderman Daniel H CHIEF FINANCIAL OFFICER
Holding Value $34.5k 10,000 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.2k 10,000 shares
$3.52
$3.45
Schramm Vern Lee Director
Holding Value $119k 34,482 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$121k 34,482 shares
$3.52
$3.45
Spoor Johan M. Director
Holding Value $276k 80,000 shares
Last Trade
Apr 06, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$464k 80,000 shares
$5.80
$3.45
Holding Value $73.9k 21,429 shares
Last Trade
Feb 14, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17.7M 1,000,000 shares
$17.70
$3.45
Shenouda Maged CHIEF FINANCIAL OFFICER
Holding Value $216k 62,500 shares
Last Trade
Dec 28, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$260k 20,000 shares
$13.00
$3.45
Dupret Daniel CHIEF SCIENTIFIC OFFICER
Holding Value $51.8k 15,000 shares
Last Trade
Jul 12, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.81M 60,000 shares
$30.10
$3.45
Holding Value $5.62M 1,627,796 shares
Last Trade
Jun 30, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.41M 60,000 shares
$40.20
$3.45

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up